DK249389A - 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer - Google Patents

2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer Download PDF

Info

Publication number
DK249389A
DK249389A DK249389A DK249389A DK249389A DK 249389 A DK249389 A DK 249389A DK 249389 A DK249389 A DK 249389A DK 249389 A DK249389 A DK 249389A DK 249389 A DK249389 A DK 249389A
Authority
DK
Denmark
Prior art keywords
acylamino
manufacture
medicinal treatments
benzothiazol
compounds
Prior art date
Application number
DK249389A
Other languages
Danish (da)
English (en)
Other versions
DK249389D0 (da
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK249389D0 publication Critical patent/DK249389D0/da
Publication of DK249389A publication Critical patent/DK249389A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Graft Or Block Polymers (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK249389A 1988-05-24 1989-05-23 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer DK249389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24

Publications (2)

Publication Number Publication Date
DK249389D0 DK249389D0 (da) 1989-05-23
DK249389A true DK249389A (da) 1989-11-27

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK249389A DK249389A (da) 1988-05-24 1989-05-23 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer

Country Status (25)

Country Link
EP (1) EP0343893B1 (pt)
JP (1) JPH0678331B2 (pt)
KR (1) KR910006864B1 (pt)
CN (1) CN1023700C (pt)
AT (1) ATE79114T1 (pt)
AU (1) AU601905B2 (pt)
CA (1) CA1328871C (pt)
DD (1) DD283815A5 (pt)
DE (1) DE68902358T2 (pt)
DK (1) DK249389A (pt)
ES (1) ES2043012T3 (pt)
FI (1) FI892498A (pt)
GR (1) GR3005844T3 (pt)
HU (1) HU202507B (pt)
IE (1) IE891667L (pt)
IL (1) IL90337A0 (pt)
MX (1) MX173140B (pt)
MY (1) MY106035A (pt)
NO (1) NO172389C (pt)
NZ (1) NZ229234A (pt)
PL (1) PL154875B1 (pt)
PT (1) PT90622B (pt)
SU (1) SU1681728A3 (pt)
YU (1) YU47019B (pt)
ZA (1) ZA893862B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
ATE203234T1 (de) * 1995-08-30 2001-08-15 Searle & Co Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
TR200001312T2 (tr) 1997-11-10 2000-09-21 Bristol-Myers Squibb Company Benzotiyazol protein tirozin kinaz önleyicileri.
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
WO1999052861A1 (de) * 1998-04-09 1999-10-21 Institut für Diagnostikforschung GmbH an der Freien Universität Berlin Neue benzylguanidinderivate für die therapie, in-vivo- und in-vitro-diagnostik
SI1303272T1 (sl) 2000-06-21 2008-06-30 Hoffmann La Roche Derivati benzotiazola za zdravljenje alzheimerjeve bolezni in parkinsonove bolezni
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
SI1753760T1 (sl) 2004-05-24 2008-04-30 Hoffmann La Roche (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid4- hidroksi-4-metil-piperidin-1-karboksilne kisline
WO2006048172A1 (en) 2004-11-05 2006-05-11 F. Hoffmann-La Roche Ag Process for preparation of isonicotinic acid derivatives
KR100973609B1 (ko) 2005-03-23 2010-08-03 에프. 호프만-라 로슈 아게 mGluR2 길항제로서 아세틸렌일-피라졸로-피리미딘유도체
DE602006013493D1 (de) 2005-09-27 2010-05-20 Hoffmann La Roche Oxadiazolylpyrazolopyrimidine als mglur2-antagonisten
WO2007104557A2 (en) * 2006-03-15 2007-09-20 4Sc Ag Novel heterocyclic nf-kb inhibitors
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2311842A3 (en) * 2008-06-24 2011-07-13 Takeda Pharmaceutical Company Limited PI3K/M TOR inhibitors
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
CN103857683B (zh) * 2011-09-30 2016-10-12 奇尼塔公司 抗病毒化合物
EP2808383B1 (en) 2012-01-27 2018-07-25 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell
WO2014136519A1 (ja) 2013-03-08 2014-09-12 国立大学法人京都大学 Egf受容体阻害剤を含む多能性幹細胞の心筋分化促進剤
EP3045451B1 (en) * 2013-09-13 2018-03-28 Kyoto University Compound promoting differentiation of pluripotent stem cells into cardiomyocytes
JP6651218B2 (ja) 2014-05-30 2020-02-19 国立大学法人京都大学 低分子化合物を用いた多能性幹細胞の心筋分化誘導法
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
NO172389B (no) 1993-04-05
SU1681728A3 (ru) 1991-09-30
YU105989A (en) 1990-08-31
KR910006864B1 (ko) 1991-09-09
ZA893862B (en) 1991-01-30
FI892498A0 (fi) 1989-05-23
FI892498A (fi) 1989-11-25
NZ229234A (en) 1990-09-26
PL154875B1 (en) 1991-09-30
CN1023700C (zh) 1994-02-09
CN1037898A (zh) 1989-12-13
EP0343893A1 (en) 1989-11-29
DK249389D0 (da) 1989-05-23
EP0343893B1 (en) 1992-08-05
GR3005844T3 (pt) 1993-06-07
DD283815A5 (de) 1990-10-24
YU47019B (sh) 1994-11-15
PT90622A (pt) 1989-11-30
IL90337A0 (en) 1989-12-15
AU3509889A (en) 1989-11-30
IE891667L (en) 1989-11-24
NO172389C (no) 1993-07-14
JPH0678331B2 (ja) 1994-10-05
ATE79114T1 (de) 1992-08-15
DE68902358D1 (de) 1992-09-10
CA1328871C (en) 1994-04-26
MX173140B (es) 1994-02-02
PL279613A1 (en) 1989-11-27
KR890017248A (ko) 1989-12-15
AU601905B2 (en) 1990-09-20
PT90622B (pt) 1994-10-31
JPH0217181A (ja) 1990-01-22
NO892059D0 (no) 1989-05-23
ES2043012T3 (es) 1993-12-16
MX16158A (es) 1993-06-01
HU202507B (en) 1991-03-28
DE68902358T2 (de) 1992-12-10
MY106035A (en) 1995-03-31
NO892059L (no) 1989-11-27
HUT51606A (en) 1990-05-28

Similar Documents

Publication Publication Date Title
DK249389D0 (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
LU90944I2 (fr) Dérivés pipérazinyl-héterocycliques
NO169839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa, alfa -(iminobis(metylen))bis(3,4-dihydro-2h-1-benzopyran-2-metanol)derivater
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
IT1190405B (it) Derivati del flavone
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
KR920700625A (ko) 고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
DE68900760D1 (de) Virushemmende nukleosidmischung.
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
NO171847C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater
DK291390D0 (da) Terapeutiske anvendelser af 2',5'-oligoadenylatderivater
ES554903A0 (es) Disposicion para el tratamiento de piezas de trabajo
IT1151104B (it) Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
DK448288D0 (da) Ethanolaminderivater
DK415087A (da) Terapeutiske midler indeholdende benzhydrylthiomethanderivater
DK702188D0 (da) Ethanolaminderivater
KR920700637A (ko) 피임을 위한 멜라토닌 유도체의 용도
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
KR890701106A (ko) 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도
SE9003704L (sv) Nya selenofenderivat, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
IT8521460A0 (it) Procedimento di preparazione di derivati eterociclici.
ES282302Y (es) Dispositivo perfeccionado para el encordado de crias del mejillon
IT8822677A0 (it) Procedimento di preparazione di derivati eterociclici.
IT8519547A0 (it) Procedimento di preparazione di derivati cefemici
LV5815A4 (lv) Benzhidriltiometana atvasinajumus saturosas terapeitiskas kompozicijas